Skip to main content
      RT @DrPetryna: Abst1625 #ACR21 @RheumNow study of kids w/covid induced MIS-C: 91% w/shock & GI ax, conjunctivitis &a

      Olga Petryna DrPetryna

      3 years 1 month ago
      Abst1625 #ACR21 @RheumNow study of kids w/covid induced MIS-C: 91% w/shock & GI ax, conjunctivitis & mucocutaneous involvement. ⬆️CRP,D-Dimer, Troponin, &BNP. On ECHO, 36% had myocardial dysfunction &27% coronary artery abnormalities. 64% required ICU admiss. Rx IVIG& steroids
      RT @ericdeinmd: #ACR21 Thieves! TM11. Belly pain in patient with RA nodules:
      ⭐️ A: rheumatoid nodulosis of pancreas

      Eric Dein ericdeinmd

      3 years 1 month ago
      #ACR21 Thieves! TM11. Belly pain in patient with RA nodules: ⭐️ A: rheumatoid nodulosis of pancreas and duodenum. Great case! @Rheumnow https://t.co/PuO4tka3FJ
      RT @DrMiniDey: Excellent overview on assessment of patients with #PsA by @AlexisOgdie!
      Really clear and easy-to-follow s

      Mrinalini Dey DrMiniDey

      3 years 1 month ago
      Excellent overview on assessment of patients with #PsA by @AlexisOgdie! Really clear and easy-to-follow slides to add structure to clinical assessment. #ACR21 @RheumNow https://t.co/XGZrCxOukm
      RT @RichardPAConway: Sub-analysis of ICHIBAN study looking at adverse events in tocilizumab treated patients with/withou

      Richard Conway RichardPAConway

      3 years 1 month ago
      Sub-analysis of ICHIBAN study looking at adverse events in tocilizumab treated patients with/without steroids. Steroids associated with small increase in adverse events across board. Abstr#1693 #ACR21 @RheumNow https://t.co/ldiovirKpo
      RT @DrMiniDey: What is the effect of #avacopan on renal function in pts with #ANCA #vasculitis?

      👉🏼Results from AD

      Mrinalini Dey DrMiniDey

      3 years 1 month ago
      What is the effect of #avacopan on renal function in pts with #ANCA #vasculitis? 👉🏼Results from ADVOCATE show greater recovery of kidney function with avacopan vs steroids 👉🏼Particularly marked in pts with CKD4 and eGFR<60 Abs#L14 #ACR21 @RheumNow https://t.co/5z7YulxVAj https://t.co/LnJr4gLuTV
      RT @RHEUMarampa: Fr AQUILA study: #Uveitis status in AS or PsA pts given SEC
      👁‍🗨3 pts w/o uveitis at BL develope

      sheila RHEUMarampa

      3 years 1 month ago
      Fr AQUILA study: #Uveitis status in AS or PsA pts given SEC 👁‍🗨3 pts w/o uveitis at BL developed new onset uveitis during study 👁‍🗨Most pts w/uveitis at BL - status remained unchanged or improved 👁‍🗨SEC did not ⬆ risk of uveitis @RheumNow #ACR21 abs1738 https://t.co/IGUpgXBLvt
      RT @DrPetryna: Abst1632 #ACR21 #ACRBest @RheumNow 25 children w/ uSAID &amp; MEFV mutations: E148Q mutation standouts-32

      Olga Petryna DrPetryna

      3 years 1 month ago
      Abst1632 #ACR21 #ACRBest @RheumNow 25 children w/ uSAID & MEFV mutations: E148Q mutation standouts-32% heterozygous for E148Q, Asian ancestry seen in 37% kids w/ E148Q. E148Q assoc w/longer febrile episodes& less likely to have a full response to colchicine (25% vs 70%; p = 0.03) https://t.co/Rst6KHntPD
      RT @doctorRBC: Predictor of PsO transition to PsA?
      Age - pts dx with PsO at 42 developed PsA 12 years sooner than pts dx

      Robert B Chao, MD doctorRBC

      3 years 1 month ago
      Predictor of PsO transition to PsA? Age - pts dx with PsO at 42 developed PsA 12 years sooner than pts dx at 18 Abs#1798 #ACR21 @RheumNow https://t.co/1zTifI3H1V https://t.co/MVP8VWicyS
      RT @DrPetryna: Abst1773 #ACR21 @rheumnow guselkumab outperforms ustekinumab in both msk &amp; skin domains in bio naive

      Olga Petryna DrPetryna

      3 years 1 month ago
      Abst1773 #ACR21 @rheumnow guselkumab outperforms ustekinumab in both msk & skin domains in bio naive & bio experienced alike- data from pivotal Phase III trials : at weeks 52 GUS better ACR20, PASI100 in both doses vs Stelara https://t.co/lfddaCJA5O
      RT @ericdeinmd: #ACR21 Thieves: SLE and SSc with worsening cytopenia and hematuria despite treatment:
      Maria Powell - pre

      Eric Dein ericdeinmd

      3 years 1 month ago
      #ACR21 Thieves: SLE and SSc with worsening cytopenia and hematuria despite treatment: Maria Powell - presents overlap case with PNH, responded to eculizumab @Rheumnow https://t.co/CGvHEMA3lI
      RT @Janetbirdope: Use your good sun screen/blocker. UV radiation is best blocked! Changes beyond skin damage and cancer.

      Janet Pope Janetbirdope

      3 years 1 month ago
      Use your good sun screen/blocker. UV radiation is best blocked! Changes beyond skin damage and cancer. Immune activation. @RheumNow #ACR21 #climate change https://t.co/VyCZR5rt8x
      Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade

      Dr. Chan ( @synovialjoints) interviews Dr. Ziade about abstract #1

      Dr. John Cush RheumNow

      3 years 1 month ago
      Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade Dr. Chan ( @synovialjoints) interviews Dr. Ziade about abstract #1787 presented at the #ACR21 annual meeting. https://t.co/Sdd1HHKRib https://t.co/ynRocjviVu
      RT @RichardPAConway: Meta-analysis of PUFA supplementation in RA. Apparent benefits across most measures, albeit often s

      Richard Conway RichardPAConway

      3 years 1 month ago
      Meta-analysis of PUFA supplementation in RA. Apparent benefits across most measures, albeit often small. Abstr#1682 #ACR21 @RheumNow https://t.co/1rGhpqvJvp
      RT @RichardPAConway: No benefit to using MTX in combination with ustekinumab in PsA. No difference in efficacy for arthr

      Richard Conway RichardPAConway

      3 years 1 month ago
      No benefit to using MTX in combination with ustekinumab in PsA. No difference in efficacy for arthritis, enthesitis, dactylitis, skin, QoL or function. Abstr#L12 #ACR21 @RheumNow https://t.co/iojKLqRb06
      RT @KDAO2011: Watch my interview w/incredible rheum leaders in the field of aging:
      👉🏼what inspired them
      👉🏼ch

      TheDaoIndex KDAO2011

      3 years 1 month ago
      Watch my interview w/incredible rheum leaders in the field of aging: 👉🏼what inspired them 👉🏼changes we need to make in our practice 👉🏼end of life care (including MD-assisted suicide). #BetterThanNPR #ACR21 @RheumNow @UnaMakris https://t.co/RBfvgHEkpm via @YouTube
      ×